Related references
Note: Only part of the references are listed.Assessment of Diagnostic Strategy for Mucous Membrane Pemphigoid
Hanan Rashid et al.
JAMA DERMATOLOGY (2021)
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I
H. Rashid et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II
E. Schmidt et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases
F. Giurdanella et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris
B. Carey et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Incidence and Clinical Characteristics of Ocular Involvement in Mucous Membrane Pemphigoid
Gloria H. Hong et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid
S. Goletz et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Mucous membrane pemphigoid of the oral lichen type: a retrospective analysis of 16 cases
M. Benzaquen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid
Joost M. Meijer et al.
JAMA DERMATOLOGY (2019)
Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
Aniek Lamberts et al.
FRONTIERS IN IMMUNOLOGY (2018)
Four cases of mucous membrane pemphigoid with clinical features of oral lichen planus
Aoi Fukuda et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA
K. T. Amber et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
Dedee F. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid
J. Taylor et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2015)
Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing
Taihei Hayakawa et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2014)
Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid
E. M. Munyangango et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Prevalence and Clinical Significance of Anti-Laminin 332 Autoantibodies Detected by a Novel Enzyme-Linked Immunosorbent Assay in Mucous Membrane Pemphigoid
Philippe Bernard et al.
JAMA DERMATOLOGY (2013)
Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients
J. B. Terra et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom
G. P. Williams et al.
EYE (2011)
Dapsone efficacy and adverse events in the management of mucous membrane pemphigoid
Anne M. Hegarty et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2010)
Immunosuppressive therapy for ocular mucous membrane pemphigoid - Strategies and outcomes
Valerie P. J. Saw et al.
OPHTHALMOLOGY (2008)
Treatment of Ocular Mucous Membrane Pemphigoid with Immunosuppressive Drug Therapy
Jennifer E. Thorne et al.
OPHTHALMOLOGY (2008)
Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa
G. T. Higgins et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity
N Oyama et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity
M Carrozzo et al.
JOURNAL OF PERIODONTOLOGY (2004)
The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators
LS Chan et al.
ARCHIVES OF DERMATOLOGY (2002)
Cicatricial pemphigoid:: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180
E Schmidt et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Anti-epiligrin cicatricial pemphigoid and relative risk for cancer
CA Egan et al.
LANCET (2001)
Cicatricial pemphigoid
TE Fleming et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Share Paper
